Trulieve Cannabis Corp. (TRLV) Stock Score, Valuation & Financial Research

Trulieve Cannabis Corp. is in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. A complete Wall Street Score is not currently available.

Quick answer for TRLV

Trulieve Cannabis Corp. does not currently have a complete Wall Street Score. The stored market price is USD 11.12. These figures are a research snapshot, not a buy or sell recommendation.

What Trulieve Cannabis Corp. does

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Company business and revenue

Research reporting period: 2025-12-31. A research update is not a new financial filing.

How the company makes money

Trulieve is a vertically integrated cannabis company that cultivates, manufactures, and retails cannabis products. It generates revenue primarily through the sale of its own branded products and third-party goods across its extensive network of retail dispensaries and through wholesale distribution channels in multiple U.S. states.

Products and services

  • Cannabis flower, concentrates, edibles, topicals, and other cannabis-derived products sold for medical and adult-use purposes.

Brands and product families

  • Avenue — Premium tier brand. Source
  • Cultivar Collection — Premium tier brand. Source
  • Muse — Premium tier brand. Source
  • Modern Flower — Branded retail product. Source
  • Momenta — Branded retail product. Source
  • Sweet Talk — Branded retail product. Source
  • Co2lors — Value tier brand. Source
  • Roll One — Value tier brand. Source

Customer types

Medical cannabis patients; Adult-use (recreational) consumers.

Suppliers, materials and equipment

  • Testing laboratories — The company utilizes third-party testing laboratories in select markets to ensure product quality and regulatory compliance; specific supplier names are unnamed. Source

Business strengths to evaluate

  • Vertically integrated operations across cultivation, manufacturing, and retail Source
  • Leading market positions in key U.S. states including Florida, Arizona, and Pennsylvania Source

Business risks and research considerations

  • Highly regulated market environment and dependence on state-level cannabis licensing Source
  • Federal illegality of cannabis in the United States Source

Sources: Company research source · Avenue · Testing laboratories · Leading market positions in key U.S. states including Florida, Arizona, and Pennsylvania

Company research refreshed 2026-10-12. This is saved research, not a live check of company relationships. Check the reporting period and source disclosures. Financial figures and scores follow their separate update schedules.

TRLV financial snapshot

Statement amounts: USD. Quote amounts: USD. No exchange-rate conversion is performed in this snapshot. Market-capitalization currency is not supplied by this projection.

Wall Street Score:
Not currently available
Stored price:
USD 11.12
Market capitalization:
1.89B (currency not supplied)
Revenue:
USD 1.14B
Net income:
USD -473.39M
Free cash flow:
USD 212.31M
Cash:
USD 325.42M
Total debt:
USD 577.26M
EPS:
USD -2.45

What stands out

  • Reported year-over-year revenue growth is -3.6%.
  • Free cash flow is USD 212.31M, positive for the stored period.
  • The balance sheet shows USD 325.42M of cash versus USD 577.26M of total debt, with debt exceeding cash on these two reported measures.
  • The current research record carries a limited financial history warning, which should be reviewed alongside the score.

Company-specific financial comparisons

The following are calculated from saved company data, not forecasts or statements about future performance. Differences in reporting dates or units can make a ratio misleading; verify the original filings.

  • Free cash flow is 18.6% of stored revenue. This is a simple cross-field ratio, not a verified same-period cash conversion margin; confirm reporting periods before comparison.
  • Net income equals -41.6% of stored revenue. This is an indicative ratio only; accounting periods and units should be verified in filings.
  • Debt exceeds cash by USD 251.84M using the stored balance-sheet values. This does not include other obligations or restricted cash.

Questions worth answering for TRLV

Use these questions to check the stored figures against the latest company filings. They identify issues to investigate; they are not findings about management's plans or future results.

  • What is driving TRLV's revenue decline, and does the latest filing suggest the weakness is temporary or structural?
  • Is TRLV's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
  • Does TRLV's balance between cash and debt leave enough flexibility if business conditions weaken?
  • What specifically needs to improve for TRLV to reach sustainable profitability?
  • What does the current limited financial history warning mean for the reliability or interpretation of TRLV's score?

What the numbers mean

A complete valuation score is not currently available, so valuation should be checked using the available earnings, cash-flow and price data.

A complete financial score is not currently available, so investors should review cash, debt, earnings and cash flow directly.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-10-01.

Research-input completeness: 64% of the scoring inputs required for this public page are currently available.

How to research TRLV

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.